Navigation Links
Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
Date:11/15/2012

Labor, High Costs and Saturation of the Market are Likely to Hinder New Drug Development in the Region 18

4.7.3 Regulatory Changes Lead to Delays in the Launch of New Drugs 18

4.7.4 Patent Expiries and Increased Consumption of Generics Threatens API Revenue Growth 18

4.7.5 Huge Deficits Provoke Cuts in Healthcare Reimbursement 19

4.8 API Total Revenue Analysis in the Americas 20

4.8.1 The Americas' Revenue Share by Product Types 22

4.8.2 The Americas' Synthetic API Total Synthetic Revenue Analysis (2005–2017) 23

4.8.3 The Americas' Synthetic API Market Revenue Share Analysis by Customer Base in 2011 28

4.8.4 The Americas' Synthetic API Revenue Trend Analysis 2005–2017 29

4.9 The Americas' Biotech API Market Analysis 31

4.9.1 The Americas' Biotech API Revenue Analysis 2005–2017 31

4.10 The Americas' Biotech API Market Revenue Analysis by Customer Base 35

4.10.1 The Americas' Biotech API Market Revenue Share Analysis by Customer Base 35

4.10.2 Patent Expiry of Leading Biologics in the Americas 36

4.10.3 The Americas' Biotech API Revenue Trend Analysis 2005–2017 37

5 North American Active Pharmaceutical Ingredients Market 39

5.1 North American API Market Overview 39

5.2 North American API Market Drivers 39

5.2.1 Continuous Growth in the Pharmaceutical Industry Sustains the API Market's Growth in North America 39

5.2.2 Generic Sector Spurs the Growth of the North American API Market 39

5.2.3 Increasing Focus on Biological Drugs Helps the API Market's Revenue Growth 39

5.3 North American API Market Restraints 39

5.3.1 Recent Economic Slowdown has Restricted the Growth of the Pharmaceutical Industry 39

5.3.2 High Cost of New Drug Development Hampers Innovation 39

5.3.3 Patent Expiries of Blockbuster Molecules will Contain the Growth of the API Market in North America 40

5.4 N
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
2. AASLD Curriculum & Training (ACT) Launches With New Interactive HCV Education
3. Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
4. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
5. Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market is Expected to Reach USD 17.5 billion in 2018: Transparency Market Research
6. Active Life Announces Launch of Next Generation BioDentTM for Life Science Research
7. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
8. According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives
9. Henry Schein Cares Disaster Relief Hotline is Active and Ready to Support Customers Affected by Hurricane Isaac
10. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
11. Cool Containers Introduces a Non-Dry Ice Active Container for Frozen Shipments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... the fourth quarter of 2013 will be approximately $53 ... million. "Our full-year revenue growth of 87% ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Calif., Oct 21 MAP Pharmaceuticals, Inc. (Nasdaq: ... of Thomas P. McCracken as Vice President, Intellectual ... property program in support of the potential commercialization ... inhaled migraine therapy, and other product opportunities. ...
... (San Francisco, CA and Ottawa, Ontario), a clinical-stage cancer ... Backer, Ph.D., to the newly-created position of senior vice ... all aspects of chemistry, manufacturing and controls (CMC) in ... pipeline products. "We are extremely pleased to ...
Cached Medicine Technology:MAP Pharmaceuticals Appoints Thomas P. McCracken as Vice President, Intellectual Property 2MAP Pharmaceuticals Appoints Thomas P. McCracken as Vice President, Intellectual Property 3Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations 2
(Date:4/22/2014)... April 22, 2014: The Association for Molecular Pathology ... Journal of Molecular Diagnostics on recommendations for ... and master,s levels of education. The report was ... Task Force of the AMP Training and Education ... need of educating future medical laboratory scientists appropriately ...
(Date:4/22/2014)... rabbits, Johns Hopkins scientists have found a way to ... the development of atherosclerosis, the main cause of heart ... among humans. The condition develops when fat builds inside ... and hardened, greatly reducing their ability to feed oxygen-rich ... In a series of experiments, described April 7 in ...
(Date:4/22/2014)... news release is available in German . ... are important intracellular signaling molecules, but their mode of ... aspects of cellular function and behavior, while at high ... membranes and DNA. To analyze how redox signaling unfolds ... optical microscopy technique has been developed jointly by the ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
(Date:4/22/2014)... all seem to know who we say is neurotic and ... unable to act but simply doesn,t want to., ... of nearly 4,000 college students in 19 countries has uncovered ... and moving forward with life. Turns out that when they ... don,t like it as much as non-neurotics. Therefore persuasive communications ...
Breaking Medicine News(10 mins):Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:Neuroimaging: Live from inside the cell 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:Neurotics don't just avoid action: They dislike it 2
... novel pancreatic cancer vaccine shows promise in improving survival when ... University Hospitals Case Medical Center,s Seidman Cancer Center and Case ... was presented today (embargoed 11:00 am ET) at the Annual ... part of Digestive Disease Week in San Diego. ...
... thousands of psychiatrists attend their field,s largest annual meeting ... drug treatments report overwhelmingly on positive results. ... the Journal of Clinical Psychopharmacology by two ... University, who analyzed the presentations given at two recent ...
... The national gastroenterology societies have issued a new document ... Sedation Curriculum for Gastrointestinal Endoscopy (MSCGE) grew out ... to the training of procedure sedation. The document is ... of Gastroenterology , GIE:Gastrointestinal Endoscopy , Hepatology ...
... The Food and Drug Administration has approved a new ... disorders. The test, or assay, was developed by an expert ... Lawrence Schwartz, M.D., Ph.D., chair of the Division of ... Professor of Medicine at VCU, has spent more than 30 ...
... Lies Van Nieuwenhove, researcher at the Antwerp Institute of ... the sleeping sickness parasite. They can be used in ... dangerous parasites. Each year many thousands of ... parasite, a trypanosome, which is transmitted by the bite ...
... TUESDAY, May 22 (HealthDay News) -- Fear of spiders, a ... therapy session, according to a small new study. People ... hold a tarantula after a two- or three-hour therapy session, ... six months, the Northwestern University researchers reported. The lasting ...
Cached Medicine News:Health News:Researchers present new findings for novel pancreatic cancer vaccine 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 3Health News:Gastroenterology Societies issue sedation curriculum for gastrointestinal endoscopy 2Health News:FDA clears test developed in partnership with VCU researcher 2Health News:Better tests for sleeping sickness 2Health News:Spider-Phobes May Get Quick Relief 2
... Vibratome Semi-Automatic Tissue Sectioning System has maintained ... sectioning system. Researchers from around the globe ... for their fresh and fresh fixed tissue ... With the Vibratome Automatic Tissue Sectioning ...
... 1500 Sectioning System provides a versatile means ... plant tissues. The 1500 employs a ... freezing or embedding. The creation of ... of enzyme activities, and other deleterious effect ...
... Semi-Automatic Tissue Sectioning System has maintained the ... system. Researchers from around the globe have ... their fresh and fresh fixed tissue sectioning ... With the Vibratome Automatic Tissue Sectioning Systems, ...
... The NEW Vibratome 3000 Plus Sectioning ... fresh or fixed, animal, or plant tissues. ... principle which allows sectioning without freezing or ... alteration of morphology, the destruction of enzyme ...
Medicine Products: